Akari Therapeutics (AKTX) EPS (Basic) (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100.00% |
| Dec 31, 2025 | -80,518.33% |
| Sep 30, 2025 | -94.59% |
| Jun 30, 2025 | 23.23% |
| Mar 31, 2025 | 99.98% |
| Dec 31, 2024 | -238,956.12% |
| Sep 30, 2024 | 61.54% |
| Jun 30, 2024 | 10.55% |
| Mar 31, 2024 | 14.30% |
| Dec 31, 2023 | -110.89% |
| Sep 30, 2023 | 52.82% |
| Jun 30, 2023 | 14.53% |
| Jun 30, 2022 | -5.23% |
| Mar 31, 2022 | 100.00% |
| Dec 31, 2021 | -13,660,284.66% |
| Sep 30, 2021 | 71.83% |
| Jun 30, 2021 | 22.49% |
| Mar 31, 2021 | 85.59% |
| Dec 31, 2020 | -13,756.65% |
| Sep 30, 2020 | 96.33% |
| Jun 30, 2020 | -100,456.10% |
| Mar 31, 2020 | -100.01% |
| Dec 31, 2019 | 1,204.95% |
| Sep 30, 2019 | -48,133.49% |
| Jun 30, 2019 | -144.78% |
| Mar 31, 2019 | 374.15% |
| Dec 31, 2018 | -60.04% |
| Sep 30, 2018 | 99.98% |
| Jun 30, 2018 | -359,672.00% |
| Mar 31, 2018 | -100.03% |
| Dec 31, 2017 | 0.00% |
| Sep 30, 2017 | 161,194.54% |
| Jun 30, 2017 | 99.94% |
| Mar 31, 2017 | 0.00% |
| Dec 31, 2016 | -748,374.62% |
| Sep 30, 2016 | -100.01% |
| Jun 30, 2016 | 394,586.40% |
| Mar 31, 2016 | -100.01% |
| Dec 31, 2015 | 133.33% |
| Sep 30, 2015 | -3,100.00% |
| Jun 30, 2015 | 200.00% |
| Mar 31, 2015 | 80.00% |
| Dec 31, 2014 | -228.82% |
| Sep 30, 2014 | 92.40% |
| Jun 30, 2014 | 0.00% |